March 26th 2025
Leveraging artificial intelligence-powered stochastic methods for clinical data review represents a significant leap beyond traditional approaches.
Artificial Intelligence Drives Industry Response to Project Optimus
February 27th 2024The FDA has taken a clear position with Project Optimus in shifting toward more progressive tailored approaches while rejecting antiquated study designs to evolve clinical trial strategies to better align with newer drug classes.